Ziopharm Oncology (ZIOP) Misses Q2 EPS Views

August 9, 2016 4:02 PM EDT
Get Alerts ZIOP Hot Sheet
Trade ZIOP Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Ziopharm Oncology (NASDAQ: ZIOP) reported Q2 EPS of ($1.01), $0.90 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.52 million.

For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment